Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma (HCC and FTC)

The Catholic University of Korea

Status

Completed

Conditions

Huerthle Cell Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT05968196

noar99

Details and patient eligibility

About

The goal of this retrospective study is to evaluate in patients with HCC and FTC who underwent lobectomy. The main questions it aims to answer are:

The necessity of completion thyroidectomy based on the clinicopathological characteristics
Prognosis Participants underwent thyroid lobectomy Researchers compared HCC and FTC groups to see the prognosis after lobectomy.

Full description

Background The prognosis of Hürthle cell carcinoma (HCC) and follicular thyroid carcinoma (FTC) is poorly understood. These types of cancers are usually confirmed after diagnostic lobectomy. We aimed to evaluate the clinicopathological characteristics and prognoses of patients with HCC and FTC who did not undergo completion thyroidectomy.

Materials and Methods We screened 221 patients diagnosed with FTC or HCC after thyroid lobectomy at Yonsei Severance Hospital between January 2000 and December 2020. After excluding patients who underwent complete thyroidectomy, 184 patients with FTC and 37 patients with HCC were included.

Enrollment

221 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria